|
Volumn 6, Issue 10, 2015, Pages
|
Reactivation of p53 via MDM2 inhibition
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
IDASANUTLIN;
LIGASE INHIBITOR;
MDM2 INHIBITOR;
NUTLIN 3;
PROTEIN MDM2;
PROTEIN P53;
SERDEMETAN;
UNCLASSIFIED DRUG;
[2 (4 TERT BUTYL 2 ETHOXYPHENYL) 4,5 BIS(4 CHLOROPHENYL) 4,5 DIHYDRO 4,5 DIMETHYL 1H IMIDAZOL 1 YL][4 [3 (METHYLSULFONYL)PROPYL] 1 PIPERAZINYL]METHANONE;
4 AMINOBENZOIC ACID DERIVATIVE;
HYPOXIA INDUCIBLE FACTOR 1ALPHA;
PYRROLIDINE DERIVATIVE;
VASCULOTROPIN A;
ANTIANGIOGENIC ACTIVITY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
ENZYME INHIBITION;
ENZYME REACTIVATION;
HUMAN;
NEUROBLASTOMA;
NEUROBLASTOMA CELL LINE;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
TUMOR XENOGRAFT;
UBIQUITINATION;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
METABOLISM;
MOUSE;
NEOVASCULARIZATION, PATHOLOGIC;
TUMOR CELL LINE;
ANIMALS;
APOPTOSIS;
CELL LINE, TUMOR;
HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT;
MICE;
NEOVASCULARIZATION, PATHOLOGIC;
NEUROBLASTOMA;
PARA-AMINOBENZOATES;
PROTO-ONCOGENE PROTEINS C-MDM2;
PYRROLIDINES;
TUMOR SUPPRESSOR PROTEIN P53;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 84975299347
PISSN: None
EISSN: 20414889
Source Type: Journal
DOI: 10.1038/cddis.2015.302 Document Type: Note |
Times cited : (18)
|
References (18)
|